CME Group Inc. (NASDAQ:CME) Shares Bought by Shelton Capital Management

by · The Cerbat Gem

Shelton Capital Management lifted its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 522.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,179 shares of the financial services provider’s stock after purchasing an additional 11,900 shares during the quarter. Shelton Capital Management’s holdings in CME Group were worth $2,839,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in CME. RB Capital Management LLC lifted its position in shares of CME Group by 11.4% during the first quarter. RB Capital Management LLC now owns 1,419 shares of the financial services provider’s stock worth $338,000 after purchasing an additional 145 shares in the last quarter. Prudential PLC acquired a new stake in shares of CME Group during the first quarter worth about $1,709,000. Cetera Investment Advisers lifted its position in shares of CME Group by 5.8% during the first quarter. Cetera Investment Advisers now owns 3,485 shares of the financial services provider’s stock worth $829,000 after purchasing an additional 190 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new stake in shares of CME Group during the first quarter worth about $281,000. Finally, Candriam Luxembourg S.C.A. increased its stake in shares of CME Group by 9.5% during the first quarter. Candriam Luxembourg S.C.A. now owns 25,230 shares of the financial services provider’s stock worth $6,001,000 after buying an additional 2,181 shares during the period. Institutional investors and hedge funds own 85.69% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on CME shares. Rosenblatt Securities restated a “sell” rating and set a $180.00 target price on shares of CME Group in a research note on Thursday, January 4th. Barclays upped their target price on shares of CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 15th. Finally, The Goldman Sachs Group lowered shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price on the stock. in a research note on Wednesday, January 3rd. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $214.22.

View Our Latest Stock Analysis on CME

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 5,560 shares of the company’s stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $216.37, for a total transaction of $1,203,017.20. Following the transaction, the director now directly owns 62,452 shares in the company, valued at $13,512,739.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other CME Group news, Director Bryan T. Durkin sold 5,560 shares of the company’s stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $216.37, for a total transaction of $1,203,017.20. Following the transaction, the director now directly owns 62,452 shares in the company, valued at $13,512,739.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Derek Sammann sold 1,862 shares of the company’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $222.07, for a total transaction of $413,494.34. Following the transaction, the insider now owns 9,694 shares in the company, valued at $2,152,746.58. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

CME Group Stock Performance

Shares of NASDAQ CME traded down $1.14 during mid-day trading on Friday, hitting $219.21. 1,775,896 shares of the company were exchanged, compared to its average volume of 1,685,721. The company has a quick ratio of 1.03, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a 50 day simple moving average of $207.58 and a 200-day simple moving average of $209.12. CME Group Inc. has a 1-year low of $174.01 and a 1-year high of $223.80. The firm has a market cap of $78.91 billion, a price-to-earnings ratio of 24.71, a price-to-earnings-growth ratio of 3.47 and a beta of 0.49.

CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.10. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same period last year, the company earned $1.92 earnings per share. The company’s revenue for the quarter was up 19.2% on a year-over-year basis. On average, sell-side analysts forecast that CME Group Inc. will post 9.6 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 26th. Investors of record on Friday, March 8th will be paid a $1.15 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date of this dividend is Thursday, March 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.10%. CME Group’s dividend payout ratio (DPR) is 49.61%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).